nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Isoprenaline—MAPK1—ovarian cancer	0.0171	1	CrCbGaD
Phenylephrine—Angiopathy—Topotecan—ovarian cancer	0.00447	0.00455	CcSEcCtD
Phenylephrine—Immune system disorder—Topotecan—ovarian cancer	0.00445	0.00453	CcSEcCtD
Phenylephrine—Mediastinal disorder—Topotecan—ovarian cancer	0.00444	0.00452	CcSEcCtD
Phenylephrine—Agitation—Chlorambucil—ovarian cancer	0.00443	0.00451	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Epirubicin—ovarian cancer	0.00436	0.00444	CcSEcCtD
Phenylephrine—Immune system disorder—Melphalan—ovarian cancer	0.00436	0.00444	CcSEcCtD
Phenylephrine—Mediastinal disorder—Melphalan—ovarian cancer	0.00435	0.00443	CcSEcCtD
Phenylephrine—Visual disturbance—Paclitaxel—ovarian cancer	0.00433	0.0044	CcSEcCtD
Phenylephrine—Arrhythmia—Melphalan—ovarian cancer	0.00431	0.00439	CcSEcCtD
Phenylephrine—Pulmonary oedema—Docetaxel—ovarian cancer	0.00426	0.00434	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Doxorubicin—ovarian cancer	0.00404	0.00411	CcSEcCtD
Phenylephrine—Stinging—Epirubicin—ovarian cancer	0.00399	0.00406	CcSEcCtD
Phenylephrine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00392	0.00398	CcSEcCtD
Phenylephrine—Angiopathy—Vinorelbine—ovarian cancer	0.00383	0.00389	CcSEcCtD
Phenylephrine—Immune system disorder—Vinorelbine—ovarian cancer	0.00381	0.00388	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vinorelbine—ovarian cancer	0.0038	0.00387	CcSEcCtD
Phenylephrine—Arrhythmia—Vinorelbine—ovarian cancer	0.00377	0.00383	CcSEcCtD
Phenylephrine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00375	0.00381	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00375	0.00381	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—ovarian cancer	0.0037	0.00377	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—ovarian cancer	0.00369	0.00375	CcSEcCtD
Phenylephrine—Visual disturbance—Docetaxel—ovarian cancer	0.00367	0.00373	CcSEcCtD
Phenylephrine—Chest pain—Topotecan—ovarian cancer	0.00365	0.00372	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00363	0.00369	CcSEcCtD
Phenylephrine—Chest pain—Melphalan—ovarian cancer	0.00358	0.00364	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—ovarian cancer	0.00358	0.00364	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00355	0.00362	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—ovarian cancer	0.00351	0.00357	CcSEcCtD
Phenylephrine—Sweating increased—Paclitaxel—ovarian cancer	0.00345	0.00351	CcSEcCtD
Phenylephrine—Nervous system disorder—Topotecan—ovarian cancer	0.00344	0.0035	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—ovarian cancer	0.00343	0.00349	CcSEcCtD
Phenylephrine—Skin disorder—Topotecan—ovarian cancer	0.0034	0.00346	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0034	0.00346	CcSEcCtD
Phenylephrine—Hyperhidrosis—Topotecan—ovarian cancer	0.00339	0.00345	CcSEcCtD
Phenylephrine—Pain—Chlorambucil—ovarian cancer	0.00337	0.00342	CcSEcCtD
Phenylephrine—Tachycardia—Melphalan—ovarian cancer	0.00335	0.00341	CcSEcCtD
Phenylephrine—Skin disorder—Melphalan—ovarian cancer	0.00333	0.00339	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—ovarian cancer	0.00333	0.00339	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.00331	0.00337	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—ovarian cancer	0.00327	0.00333	CcSEcCtD
Phenylephrine—Palpitations—Vinorelbine—ovarian cancer	0.00325	0.0033	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—ovarian cancer	0.00324	0.0033	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00318	0.00323	CcSEcCtD
Phenylephrine—Abdominal pain upper—Docetaxel—ovarian cancer	0.00318	0.00323	CcSEcCtD
Phenylephrine—Hypertension—Vinorelbine—ovarian cancer	0.00317	0.00323	CcSEcCtD
Phenylephrine—Paraesthesia—Topotecan—ovarian cancer	0.00315	0.0032	CcSEcCtD
Phenylephrine—Urticaria—Chlorambucil—ovarian cancer	0.00313	0.00318	CcSEcCtD
Phenylephrine—Chest pain—Vinorelbine—ovarian cancer	0.00313	0.00318	CcSEcCtD
Phenylephrine—Dyspnoea—Topotecan—ovarian cancer	0.00312	0.00318	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00312	0.00317	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.0031	0.00316	CcSEcCtD
Phenylephrine—Myocardial infarction—Paclitaxel—ovarian cancer	0.0031	0.00315	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—ovarian cancer	0.00308	0.00314	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00308	0.00313	CcSEcCtD
Phenylephrine—Paraesthesia—Melphalan—ovarian cancer	0.00308	0.00313	CcSEcCtD
Phenylephrine—Dyspnoea—Melphalan—ovarian cancer	0.00306	0.00311	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—ovarian cancer	0.00303	0.00308	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00302	0.00308	CcSEcCtD
Phenylephrine—Pain—Topotecan—ovarian cancer	0.003	0.00305	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00296	0.00301	CcSEcCtD
Phenylephrine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00294	0.00299	CcSEcCtD
Phenylephrine—Pain—Melphalan—ovarian cancer	0.00293	0.00298	CcSEcCtD
Phenylephrine—Tachycardia—Vinorelbine—ovarian cancer	0.00293	0.00298	CcSEcCtD
Phenylephrine—Skin disorder—Vinorelbine—ovarian cancer	0.00291	0.00296	CcSEcCtD
Phenylephrine—Hypersensitivity—Chlorambucil—ovarian cancer	0.0029	0.00295	CcSEcCtD
Phenylephrine—Bradycardia—Paclitaxel—ovarian cancer	0.00289	0.00294	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—ovarian cancer	0.00288	0.00293	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—ovarian cancer	0.00285	0.0029	CcSEcCtD
Phenylephrine—Pruritus—Chlorambucil—ovarian cancer	0.00278	0.00283	CcSEcCtD
Phenylephrine—Urticaria—Topotecan—ovarian cancer	0.00278	0.00283	CcSEcCtD
Phenylephrine—Visual impairment—Paclitaxel—ovarian cancer	0.00273	0.00278	CcSEcCtD
Phenylephrine—Urticaria—Melphalan—ovarian cancer	0.00273	0.00277	CcSEcCtD
Phenylephrine—Paraesthesia—Vinorelbine—ovarian cancer	0.00269	0.00274	CcSEcCtD
Phenylephrine—Dyspnoea—Vinorelbine—ovarian cancer	0.00267	0.00272	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00266	0.00271	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00264	0.00269	CcSEcCtD
Phenylephrine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00263	0.00268	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—ovarian cancer	0.00263	0.00267	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—ovarian cancer	0.0026	0.00264	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00259	0.00263	CcSEcCtD
Phenylephrine—Hypersensitivity—Topotecan—ovarian cancer	0.00258	0.00263	CcSEcCtD
Phenylephrine—Angiopathy—Paclitaxel—ovarian cancer	0.00257	0.00262	CcSEcCtD
Phenylephrine—Pain—Vinorelbine—ovarian cancer	0.00256	0.00261	CcSEcCtD
Phenylephrine—Immune system disorder—Paclitaxel—ovarian cancer	0.00256	0.00261	CcSEcCtD
Phenylephrine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00256	0.0026	CcSEcCtD
Phenylephrine—Arrhythmia—Paclitaxel—ovarian cancer	0.00253	0.00258	CcSEcCtD
Phenylephrine—Hypersensitivity—Melphalan—ovarian cancer	0.00253	0.00257	CcSEcCtD
Phenylephrine—Vomiting—Chlorambucil—ovarian cancer	0.0025	0.00255	CcSEcCtD
Phenylephrine—Mental disorder—Paclitaxel—ovarian cancer	0.00249	0.00253	CcSEcCtD
Phenylephrine—Pruritus—Topotecan—ovarian cancer	0.00248	0.00252	CcSEcCtD
Phenylephrine—Pruritus—Melphalan—ovarian cancer	0.00243	0.00247	CcSEcCtD
Phenylephrine—Tension—Paclitaxel—ovarian cancer	0.00242	0.00247	CcSEcCtD
Phenylephrine—Dysgeusia—Paclitaxel—ovarian cancer	0.00242	0.00246	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—ovarian cancer	0.0024	0.00245	CcSEcCtD
Phenylephrine—Nervousness—Paclitaxel—ovarian cancer	0.0024	0.00244	CcSEcCtD
Phenylephrine—Urticaria—Vinorelbine—ovarian cancer	0.00238	0.00242	CcSEcCtD
Phenylephrine—Nausea—Chlorambucil—ovarian cancer	0.00234	0.00238	CcSEcCtD
Phenylephrine—Vision blurred—Paclitaxel—ovarian cancer	0.00233	0.00237	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—ovarian cancer	0.00232	0.00236	CcSEcCtD
Phenylephrine—Dizziness—Topotecan—ovarian cancer	0.00232	0.00236	CcSEcCtD
Phenylephrine—Tremor—Paclitaxel—ovarian cancer	0.00231	0.00235	CcSEcCtD
Phenylephrine—Agitation—Paclitaxel—ovarian cancer	0.00227	0.00231	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—ovarian cancer	0.00223	0.00227	CcSEcCtD
Phenylephrine—Vomiting—Topotecan—ovarian cancer	0.00223	0.00227	CcSEcCtD
Phenylephrine—Syncope—Paclitaxel—ovarian cancer	0.00222	0.00225	CcSEcCtD
Phenylephrine—Rash—Topotecan—ovarian cancer	0.00221	0.00225	CcSEcCtD
Phenylephrine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00221	0.00225	CcSEcCtD
Phenylephrine—Dermatitis—Topotecan—ovarian cancer	0.00221	0.00225	CcSEcCtD
Phenylephrine—Headache—Topotecan—ovarian cancer	0.00219	0.00223	CcSEcCtD
Phenylephrine—Palpitations—Paclitaxel—ovarian cancer	0.00218	0.00222	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—ovarian cancer	0.00218	0.00222	CcSEcCtD
Phenylephrine—Vomiting—Melphalan—ovarian cancer	0.00218	0.00222	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—ovarian cancer	0.00217	0.00221	CcSEcCtD
Phenylephrine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00217	0.00221	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00217	0.00221	CcSEcCtD
Phenylephrine—Rash—Melphalan—ovarian cancer	0.00216	0.0022	CcSEcCtD
Phenylephrine—Dermatitis—Melphalan—ovarian cancer	0.00216	0.0022	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—ovarian cancer	0.00215	0.00219	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00214	0.00218	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00214	0.00218	CcSEcCtD
Phenylephrine—Hypertension—Paclitaxel—ovarian cancer	0.00213	0.00217	CcSEcCtD
Phenylephrine—Pruritus—Vinorelbine—ovarian cancer	0.00212	0.00216	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—ovarian cancer	0.00211	0.00214	CcSEcCtD
Phenylephrine—Chest pain—Paclitaxel—ovarian cancer	0.0021	0.00214	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00209	0.00212	CcSEcCtD
Phenylephrine—Nausea—Topotecan—ovarian cancer	0.00208	0.00212	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—ovarian cancer	0.00205	0.00209	CcSEcCtD
Phenylephrine—Nausea—Melphalan—ovarian cancer	0.00204	0.00207	CcSEcCtD
Phenylephrine—Shock—Paclitaxel—ovarian cancer	0.00198	0.00202	CcSEcCtD
Phenylephrine—Dizziness—Vinorelbine—ovarian cancer	0.00198	0.00202	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00198	0.00202	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00198	0.00202	CcSEcCtD
Phenylephrine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00198	0.00201	CcSEcCtD
Phenylephrine—Tachycardia—Paclitaxel—ovarian cancer	0.00197	0.002	CcSEcCtD
Phenylephrine—Skin disorder—Paclitaxel—ovarian cancer	0.00196	0.00199	CcSEcCtD
Phenylephrine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00195	0.00198	CcSEcCtD
Phenylephrine—Vomiting—Vinorelbine—ovarian cancer	0.00191	0.00194	CcSEcCtD
Phenylephrine—Rash—Vinorelbine—ovarian cancer	0.00189	0.00192	CcSEcCtD
Phenylephrine—Dermatitis—Vinorelbine—ovarian cancer	0.00189	0.00192	CcSEcCtD
Phenylephrine—Headache—Vinorelbine—ovarian cancer	0.00188	0.00191	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—ovarian cancer	0.00188	0.00191	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—ovarian cancer	0.00185	0.00188	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—ovarian cancer	0.00184	0.00187	CcSEcCtD
Phenylephrine—Paraesthesia—Paclitaxel—ovarian cancer	0.00181	0.00184	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—ovarian cancer	0.00181	0.00184	CcSEcCtD
Phenylephrine—Dyspnoea—Paclitaxel—ovarian cancer	0.0018	0.00183	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—ovarian cancer	0.00178	0.00181	CcSEcCtD
Phenylephrine—Nausea—Vinorelbine—ovarian cancer	0.00178	0.00181	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00177	0.0018	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00174	0.00177	CcSEcCtD
Phenylephrine—Pain—Paclitaxel—ovarian cancer	0.00172	0.00175	CcSEcCtD
Phenylephrine—Shock—Docetaxel—ovarian cancer	0.00168	0.00171	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—ovarian cancer	0.00168	0.0017	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—ovarian cancer	0.00167	0.0017	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—ovarian cancer	0.00166	0.00169	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—ovarian cancer	0.00165	0.00168	CcSEcCtD
Phenylephrine—Urticaria—Paclitaxel—ovarian cancer	0.0016	0.00163	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—ovarian cancer	0.00156	0.00159	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—ovarian cancer	0.00153	0.00156	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—ovarian cancer	0.00153	0.00155	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—ovarian cancer	0.00152	0.00155	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—ovarian cancer	0.00151	0.00153	CcSEcCtD
Phenylephrine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00149	0.00151	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00148	0.0015	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—ovarian cancer	0.00147	0.0015	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—ovarian cancer	0.00147	0.00149	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00146	0.00149	CcSEcCtD
Phenylephrine—Pain—Docetaxel—ovarian cancer	0.00146	0.00149	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—ovarian cancer	0.00145	0.00147	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—ovarian cancer	0.00145	0.00147	CcSEcCtD
Phenylephrine—Pruritus—Paclitaxel—ovarian cancer	0.00143	0.00145	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—ovarian cancer	0.00142	0.00145	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00139	0.00142	CcSEcCtD
Phenylephrine—Tension—Epirubicin—ovarian cancer	0.00139	0.00141	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—ovarian cancer	0.00138	0.00141	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—ovarian cancer	0.00137	0.0014	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—ovarian cancer	0.00136	0.00139	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—ovarian cancer	0.00136	0.00138	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00135	0.00138	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—ovarian cancer	0.00134	0.00136	CcSEcCtD
Phenylephrine—Dizziness—Paclitaxel—ovarian cancer	0.00133	0.00136	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—ovarian cancer	0.00133	0.00135	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—ovarian cancer	0.00132	0.00134	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—ovarian cancer	0.0013	0.00132	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—ovarian cancer	0.00128	0.0013	CcSEcCtD
Phenylephrine—Vomiting—Paclitaxel—ovarian cancer	0.00128	0.0013	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—ovarian cancer	0.00128	0.0013	CcSEcCtD
Phenylephrine—Rash—Paclitaxel—ovarian cancer	0.00127	0.00129	CcSEcCtD
Phenylephrine—Dermatitis—Paclitaxel—ovarian cancer	0.00127	0.00129	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—ovarian cancer	0.00127	0.00129	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—ovarian cancer	0.00127	0.00129	CcSEcCtD
Phenylephrine—Headache—Paclitaxel—ovarian cancer	0.00126	0.00128	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—ovarian cancer	0.00126	0.00128	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—ovarian cancer	0.00124	0.00126	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—ovarian cancer	0.00123	0.00125	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—ovarian cancer	0.00122	0.00124	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—ovarian cancer	0.00121	0.00123	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Phenylephrine—Nausea—Paclitaxel—ovarian cancer	0.0012	0.00122	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00119	0.00121	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—ovarian cancer	0.00117	0.00119	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—ovarian cancer	0.00115	0.00117	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00115	0.00117	CcSEcCtD
Phenylephrine—Shock—Epirubicin—ovarian cancer	0.00113	0.00115	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—ovarian cancer	0.00113	0.00115	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—ovarian cancer	0.00113	0.00115	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—ovarian cancer	0.00113	0.00115	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00111	0.00113	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—ovarian cancer	0.00111	0.00113	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.0011	0.00112	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—ovarian cancer	0.00109	0.00111	CcSEcCtD
Phenylephrine—Rash—Docetaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Phenylephrine—Headache—Docetaxel—ovarian cancer	0.00107	0.00109	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00105	0.00106	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—ovarian cancer	0.00104	0.00105	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000995	0.00101	CcSEcCtD
Phenylephrine—Pain—Epirubicin—ovarian cancer	0.000986	0.001	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—ovarian cancer	0.000958	0.000974	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—ovarian cancer	0.000951	0.000967	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000921	0.000937	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—ovarian cancer	0.000916	0.000931	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—ovarian cancer	0.000912	0.000928	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—ovarian cancer	0.000849	0.000864	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—ovarian cancer	0.000847	0.000862	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—ovarian cancer	0.000815	0.00083	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000786	0.000799	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—ovarian cancer	0.000762	0.000775	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—ovarian cancer	0.000754	0.000768	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—ovarian cancer	0.000733	0.000746	CcSEcCtD
Phenylephrine—Rash—Epirubicin—ovarian cancer	0.000727	0.000739	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—ovarian cancer	0.000726	0.000739	CcSEcCtD
Phenylephrine—Headache—Epirubicin—ovarian cancer	0.000722	0.000735	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—ovarian cancer	0.000705	0.000717	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—ovarian cancer	0.000685	0.000696	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—ovarian cancer	0.000678	0.00069	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—ovarian cancer	0.000672	0.000684	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—ovarian cancer	0.000672	0.000683	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—ovarian cancer	0.000668	0.00068	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—ovarian cancer	0.000633	0.000644	CcSEcCtD
